Doctor of Podiatric Medicine Program year 2025 Source: CMS Open Payments, 2026 publication

Kaina Louis-Charles

Podiatrist, Foot & Ankle Surgery Boynton Beach, FL Doctor of Podiatric Medicine

NPI 1932841954 CMS profile 11917772

1325 S Congress Ave Ste 108, Boynton Beach, FL 33426

Open in the dashboard

General payments

$7,826

72 records reported · program year 2025

Research payments

$0

Paid to them · None reported · program year 2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kaina Louis-Charles of Boynton Beach, FL is reported in the CMS Open Payments database as having received $7,826 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2025 General $7,826 72

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kaina Louis-Charles
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Kaina Louis-Charles were reported at $7,826. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Kaina Louis-Charles Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $0 $389 $118–$1,406 $163
2020 $0 $191 $62–$691 $114
2021 $0 $329 $104–$1,341 $132
2022 $0 $419 $125–$1,611 $149
2023 $0 $377 $128–$1,164 $160
2024 $0 $394 $134–$1,168 $164
2025 $7,826 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program year 2025
  1. Stryker Corporation $2,514 19 payments
  2. Treace Medical Concepts, Inc. $1,986 24 payments
  3. Medical Device Business Services, Inc. $964 6 payments
  4. Paragon 28, Inc. $554 3 payments
  5. Linvatec Corporation $323 2 payments
  6. Organogenesis Inc. $319 3 payments
  7. Integra LifeSciences Corporation $213 3 payments
  8. Smith+Nephew, Inc. $204 3 payments
  9. DePuy Synthes Sales Inc. $151 2 payments
  10. Zimmer Biomet Holdings, Inc. $138 1 payment
  11. Other $460 6 payments

Every payment, record by record

What the payments were for General payments · program year 2025
  1. Food and Beverage $4,139 60 payments
  2. Travel and Lodging $3,688 12 payments
Products named General payments · program year 2025
  1. MOTOBAND $1,115 8 payments
  2. PROSTEP $937 3 payments
  3. LAPIPLASTY $680 2 payments
  4. MONKEY RINGS $554 3 payments
  5. PROSTEP MICA $520 3 payments
  6. VARIAX $456 7 payments
  7. ORTHOLOC 3DI $429 1 payment
  8. TMC PSI CUT GUIDE SYSTEM $409 3 payments
  9. BIOBRACE 23MM $323 2 payments
  10. PURAPLY WOUND MATRIX $319 3 payments
  11. Other $3,436 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record